Senores Pharmaceuticals IPO GMP, Open Date, Price Band, Allotment Status

Senores Pharmaceuticals IPO open date is on 20 December to 24 December 2024.This new IPO is a book-built issue of Rs 582.11 crore. This upcoming IPO is a combination of fresh issue and offer-for-sale. The fresh issue is of Rs 500 crore and offer-for-sale is of Rs 82.11 crore.

Senores Pharmaceuticals IPO price band is Rs 372 to Rs 391. As of now, Senores Pharmaceuticals IPO GMP Live is Rs 210 per share indicates mild bullish sentiment for this IPO among investors. Live IPO Grey Market Premium details are visible online. 

Senores Pharmaceuticals IPO lot size is 38 shares and the allotment status live is finalised on Thursday, December 26, 2024. The minimum investment for the retail investors for 1 lot is Rs 14,858. The registrar for the Senores Pharmaceuticals IPO is Link Intime India Private Limited. The IPO listing date is 30 December 2024.

Also Read | Sagility India IPO GMP, Price Band, Open Date, Allotment Status

Senores Pharmaceuticals IPO GMP

Senores Pharmaceuticals IPO Open Date, Close Date

Senores Pharmaceuticals IPO open date is Friday, 20 December 2024 and closing will be on Tuesday, 24 December 2024. Initiation of refund date is 27 December 2024 and credit of shares will be on 27 December 2024.

Senores Pharmaceuticals IPO Price Band

Senores Pharmaceuticals IPO Allotment Status

Senores Pharmaceuticals IPO Listing Date

Senores Pharmaceuticals IPO's listing date is 30 December 2024. The Listing will be on both the NSE and BSE exchanges. Retail investors can sell the shares after 10 AM on the listing day.

Senores Pharmaceuticals IPO: Listing Date, Lot Size, Price Band

Senores Pharmaceuticals IPO : About the Company

Senores Pharmaceuticals Limited started in 2017 with the aim of finding and developing and manufacturing various quantities of specialty and complex pharmaceutical drugs. By March 2024, the firm had already released 54 drugs in strategic therapeutic categories consisting of antibiotics, antibacterials, antifungals, as well as treatment for blood.

The company has three R&D facilities, two in India and one in the US. The company is planning to merge these three into a single dedicated facility in Ahmedabad.

The company is growing into the future by expanding its Atlanta site through a brownfield project and enhancing its R&D capacity with new laboratory equipment. Besides, it is planning to set up a specialised injectables manufacturing facility in the US for the production and marketing of high-value injectables in the American market.

Senores Pharmaceuticals IPO Objectives

Senores Pharmaceuticals IPO funds will be utilised for setting up a manufacturing plant for the production of sterile injections. Also, the funds will be used for meeting the day-to-day capital needs of the company and funding the subsidiaries. The remaining money will be utilised in the payment of Debt.

Senores Pharmaceuticals IPO: Key Dates, Allotment, Listing Date

Senores Pharmaceuticals IPO Subscription Details, IPO Reservation

Senores Pharmaceuticals IPO Lot Size Details

Senores Pharmaceuticals IPO Promoter Holdings

Senores Pharmaceuticals IPO promoters are Swapnil Jatinbhai Shah, Ashok Kumar Vijaysinh Barot and Sangeeta Mukur Barot. The promoters' shareholdings before the IPO were x%; however, after the IPO, shareholdings will decline.

Senores Pharmaceuticals IPO Registrar

Senores Pharmaceuticals IPO registrar is Link Intime India Private Limited. On the date of allotment, Investors can click on the registrar website and select the name of the company and enter PAN number or application ID to know their allotment status.

Senores Pharmaceuticals IPO Lead Managers

Senores Pharmaceuticals IPO lead managers are Equirus Capital, Ambit, and Nuvama Wealth Management.

How to apply to Senores Pharmaceuticals IPO

Interested investors can apply to the Senores Pharmaceuticals IPO directly from the Bigul trading app and you can also apply by clicking here. Investors can also check the details of other upcoming IPO in Bigul.

Senores Pharmaceuticals IPO Review

Senores Pharmaceuticals IPO may get a positive response from the general public. The company is involved in the pharma business. So, investors interested in the pharmaceutical sector can apply to this IPO. This upcoming IPO is expected to witness an oversubscription in the last bidding date. Moreover, if the IPO gets a positive response then Senores Pharmaceuticals IPO GMP will also rise.

Senores Pharmaceuticals IPO FAQ

1. What are the details of the Senores Pharmaceuticals IPO?

Senores Pharmaceuticals IPO is a book-built issue of Rs 800 crores. This upcoming IPO is likely to be a combination of fresh issue and offer-for-sale. The fresh Issue is of Rs 500 crore and OFS is of 27 lakh equity shares.

2. When will the Senores Pharmaceuticals IPO open and close?

Senores Pharmaceuticals IPO open date is Friday, 20 December 2024 and closing will be on Tuesday, 24 December 2024. Initiation of refund date is 27 December 2024 and credit of shares will be on 27 December 2024.

3. What is Senores Pharmaceuticals IPO GMP?

4. What are the details of Senores Pharmaceuticals IPO Subscription Status?

5. Write the details of the IPO Allotment Status?

6. Who is the registrar and lead managers for Senores Pharmaceuticals IPO?

Senores Pharmaceuticals IPO's registrar is Link Intime India Private Limited. On the date of allotment, Investors can click on the registrar's website and select the name of the company and enter PAN number or application ID to know their allotment status.The lead managers are Equirus Capital, Ambit and Nuvama Wealth Management.

Also Read:

• What is IPO?
• What is IPO GMP?
• Difference between IPO and FPO For Beginners
• Difference between SME IPO and Mainline IPO?